Characteristics of orphan drug applications that fail to achieve marketing approval in the USA

H.E. Heemstra; H.G.M. Leufkens; R.P. Rodgers; K. Xu; B.C. Voordouw; M. Braun

Characteristics of orphan drug applications that fail to achieve marketing approval in the USA

H.E. Heemstra
, H.G.M. Leufkens
, R.P. Rodgers
, K. Xu
, B.C. Voordouw
, M. Braun

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	73-80
Number of pages	8
Journal	Drug Discovery Today
Volume	16
Issue number	1-2
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Farmacie/Biofarmaceutische wetenschappen (FARM)
Epidemiology
Farmacie(FARM)
Biomedische technologie en medicijnen
Ziekenhuisstructuur en organisatie van de gezondheidszorg
Public Health

Cite this

@article{8643e0aa98224725a64c8aba3150a93a,

title = "Characteristics of orphan drug applications that fail to achieve marketing approval in the USA",

keywords = "Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health",

author = "H.E. Heemstra and H.G.M. Leufkens and R.P. Rodgers and K. Xu and B.C. Voordouw and M. Braun",

year = "2011",

language = "Undefined/Unknown",

volume = "16",

pages = "73--80",

journal = "Drug Discovery Today",

issn = "1359-6446",

publisher = "Elsevier Ltd",

number = "1-2",

}

TY - JOUR

T1 - Characteristics of orphan drug applications that fail to achieve marketing approval in the USA

AU - Heemstra, H.E.

AU - Leufkens, H.G.M.

AU - Rodgers, R.P.

AU - Xu, K.

AU - Voordouw, B.C.

AU - Braun, M.

PY - 2011

Y1 - 2011

KW - Farmacie/Biofarmaceutische wetenschappen (FARM)

KW - Epidemiology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Ziekenhuisstructuur en organisatie van de gezondheidszorg

KW - Public Health

M3 - Article

SN - 1359-6446

VL - 16

SP - 73

EP - 80

JO - Drug Discovery Today

JF - Drug Discovery Today

IS - 1-2

ER -